Simponi



Indications and Reactions:

Role Indications Reactions
Primary
Rheumatoid Arthritis 54.8%
Product Used For Unknown Indication 11.0%
Psoriatic Arthropathy 7.4%
Ankylosing Spondylitis 6.8%
Prophylaxis 5.1%
Hypertension 3.2%
Pain 1.6%
Arthritis 1.5%
Osteoporosis 1.4%
Ill-defined Disorder 0.9%
Gastrooesophageal Reflux Disease 0.9%
Diabetes Mellitus 0.8%
Blood Pressure 0.7%
Depression 0.7%
Psoriasis 0.6%
Asthma 0.6%
Hypothyroidism 0.5%
Colitis Ulcerative 0.5%
Thyroid Disorder 0.5%
Crohn's Disease 0.5%
Pneumonia 25.5%
Vomiting 5.8%
Herpes Zoster 5.4%
Cellulitis 5.3%
Drug Dose Omission 5.3%
Infection 5.3%
Urinary Tract Infection 4.6%
Pyrexia 4.5%
Pain 3.7%
Tuberculosis 3.5%
Sepsis 3.4%
Weight Decreased 3.4%
Neoplasm Malignant 3.3%
Death 3.1%
Drug Ineffective 3.1%
Dyspnoea 3.1%
Rheumatoid Arthritis 3.1%
Skin Cancer 3.1%
Breast Cancer 3.0%
Headache 2.9%
Secondary
Rheumatoid Arthritis 66.9%
Prophylaxis 9.7%
Product Used For Unknown Indication 5.4%
Psoriatic Arthropathy 4.4%
Ankylosing Spondylitis 2.7%
Hypertension 2.1%
Osteoporosis 1.6%
Psoriasis 0.8%
Pain 0.8%
Arthritis 0.7%
Gastrooesophageal Reflux Disease 0.7%
Crohn's Disease 0.6%
Insomnia 0.5%
Seronegative Arthritis 0.5%
Diabetes Mellitus 0.5%
Constipation 0.5%
Asthma 0.4%
Prophylaxis Against Gastrointestinal Ulcer 0.4%
Depression 0.4%
Gastritis 0.3%
Pneumonia 18.5%
Vomiting 6.9%
Tuberculosis 6.5%
Cell Marker Increased 5.9%
Bronchopneumonia 5.3%
Pyelonephritis 5.1%
Urinary Tract Infection 4.8%
Herpes Zoster 4.7%
Rheumatoid Arthritis 4.7%
Drug Ineffective 4.1%
Renal Disorder 4.1%
Hepatic Function Abnormal 3.9%
Liver Disorder 3.8%
Pyrexia 3.6%
Interstitial Lung Disease 3.3%
Keloid Scar 3.3%
Pneumocystis Jirovecii Pneumonia 3.2%
White Blood Cell Count Decreased 3.0%
Syncope 2.9%
Pneumonia Bacterial 2.7%
Concomitant
Rheumatoid Arthritis 31.7%
Product Used For Unknown Indication 19.7%
Psoriatic Arthropathy 13.1%
Ankylosing Spondylitis 8.2%
Psoriasis 7.9%
Hypertension 2.3%
Arthritis 2.1%
Pain 2.1%
Tendonitis 1.5%
Breakthrough Pain 1.3%
Nausea 1.3%
Vitamin Supplementation 1.3%
Muscle Relaxant Therapy 1.1%
Osteoarthritis 1.1%
Arthralgia 1.0%
Hepatitis C 1.0%
Inflammation 1.0%
Depression 0.8%
Fibromyalgia 0.8%
Inflammatory Bowel Disease 0.8%
Drug Ineffective 16.1%
Therapeutic Response Decreased 13.5%
Rheumatoid Arthritis 6.5%
Psoriasis 5.8%
Sinusitis 5.8%
Injection Site Reaction 5.2%
Pain 5.2%
Pain In Extremity 5.2%
Wrong Technique In Drug Usage Process 4.5%
Injection Site Pain 3.9%
Injection Site Swelling 3.9%
Musculoskeletal Stiffness 3.2%
Urticaria 3.2%
Arthralgia 2.6%
Injection Site Warmth 2.6%
Malaise 2.6%
Psoriatic Arthropathy 2.6%
Rash 2.6%
Squamous Cell Carcinoma 2.6%
Swelling 2.6%